ABLLL vs HCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

ABLLL

51.3
AI Score
VS
ABLLL Wins

HCAT

44.9
AI Score

Investment Advisor Scores

ABLLL

51score
Recommendation
HOLD

HCAT

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABLLL HCAT Winner
Forward P/E 0 7.764 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -12.7% ABLLL
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 51.3/100 44.9/100 ABLLL
Profit Margin 0.0% -90.6% ABLLL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABLLL 1M: +1.4% · 3M: +1.6% HCAT 1M: -5.0% · 3M: +3.7%

Current Technical Phase

ABLLL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.4 · Price: $25.46

HCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $1.70

Fundamentals Snapshot

Metric ABLLL HCAT
Market Cap
Forward P/E 0.0 215.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.1%
Gross Margin 0.5%
Operating Margin 0.0% -0.1%
EPS 0.00 -3.68
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, ABLLL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.